Fig. 1: Survival outcomes comparison between 2-cycle and 3-cycle IC of the low-risk group after PSM.

a Progression-free survival after PSM; b Overall survival after PSM; c Distant metastasis-free survival after PSM; d Locoregional recurrence-free survival after PSM.